WELCOME TO INTERNATIONAL JOURNAL OF PHARMACEUTICAL  SCIENCE AND HEALTH CARE

 ISSN 2249 – 5738

noW INDEXED IN

                US National Library of Medicine National Institutes of Health

Impact Factor:  3.11 (Included as isi journal in master list of various data base)

Objectives

The objectives of IJPHC are to promote dialogue among researchers from multiple disciplines and the advancement of innovative biotechnology, biological, medical and pharmaceutical sciences. The journal also seeks to establish an effective communication channel between government agencies and academic and research institutions. The International Journal of Pharmaceutical Sciences and Health Care (IJPHC) is a bimonthly published online Journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences and health care (Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest. The objectives of IJPHC are to establish an effective channel of communication between researchers and practitioners, government agencies, academic and research institutions and persons concerned with the complex roles of biomedical engineering and technology. It also aims to promote and coordinate developments in the field from the laboratory bench to the patient’s bedside. Healthcare is a global industry; the international dimension is therefore emphasized in order to facilitate the development of solutions that have a universal focus.

All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay.

 Readership

The audience of IJPHC consists of scientists, researchers, medical and pharmaceutical practitioners, academics, graduate students, professionals and engineers working and interested in learning about new trends in computational biology and drug design. 

Contents

IJPHC publishes original papers, application papers, review papers, technical reports, case studies, conference reports, management reports, book reviews, notes, commentaries, and news. Special Issues devoted to important research topics and major international conferences in the fields will occasionally be published

Editorial policy

The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors. Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research.

Subject Coverage

Keeping the interactive objectives of the journal

in mind, IJPHC solicits original and application

contributions in the following non-exclusive

lists of areas:

•  Biomolecular dynamics
•  Protein docking
•  Ligand–receptor interactions
•  High-throughput drug screening
•  Drug discovery
•  Drug design
•  Biomolecular and phylogenetic databases
•  Biolanguages, interoperability in biodatabases, bioontology and data mining
•  Identification and classification of genes
•  Sequence search and alignment
•  Protein structure prediction and molecular simulation
•  Molecular evolution and phylogeny
•  Functional genomics
•  Proteomics
•  Gene expression analysis
•  Bioinformatics engineering
•  Biodata visualisation
•  Systems biology
•  Algorithms, modelling and simulation of biosets
•  Biomarkers of toxicity
•  Cellular signalling and communications
•  Biological systems and models
•  Engineering models in biomedicine
•  Monte Carlo simulation
•  Biological modelling
•  Cell engineering
•  Molecular and cellular systems
•  Body and cell biosignatures
•  Biomarkers
•  Microarray technologies
•  Biomedical data engineering
•  Healthcare economics and management on the macro and micro levels
•  Healthcare technology management and technology assessment
•  Medical technology management
•  Strategic management and organization of healthcare and healthcare technology (HC/HCT)
•  Human resource management and HC/HCT
•  Organisation behaviour and organisation theory in HC/HCT
•  R&D management and HC/HCT
•  Entrepreneurial management and HC/HCT
•  Innovation and new product development and HC/HCT
•  Operations management and HC/HCT